GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
Circulation (New York, N.Y.), 2022-12, Vol.146 (24), p.1882-1894 [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.059595 ;PMID: 36508493
Full text available